Ind-Swift Limited Sustainability Profile
Ind-Swift Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1986, the company has established itself as a leader in the production of high-quality active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a diverse portfolio that includes a range of therapeutic segments, Ind-Swift Limited is renowned for its commitment to innovation and quality. The company’s state-of-the-art manufacturing facilities and adherence to stringent regulatory standards set it apart in a competitive landscape. Notable achievements include significant expansions and partnerships that have bolstered its market position, making Ind-Swift a trusted name in healthcare solutions.
DitchCarbon Score
How does Ind-Swift Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ind-Swift Limited's score of 16 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ind-Swift Limited's reported carbon emissions
Ind-Swift Limited, headquartered in India, currently does not report specific carbon emissions data, as indicated by the absence of figures in the latest emissions dataset. The company is a current subsidiary of Ind-Swift Laboratories Limited, which may influence its climate-related initiatives and reporting. Despite the lack of direct emissions data, Ind-Swift Limited's commitment to climate action can be inferred through its association with its parent company. However, no specific reduction targets or climate pledges have been documented for Ind-Swift Limited at this time. The absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. As a participant in the pharmaceutical industry, Ind-Swift Limited operates in a sector increasingly scrutinised for its environmental impact. The company may benefit from aligning its strategies with industry standards and best practices to enhance its sustainability profile and address climate change effectively.
How Carbon Intensive is Ind-Swift Limited's Industry?
How Carbon Intensive is Ind-Swift Limited's Location?
Ind-Swift Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ind-Swift Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
